472
M. Bruno et al. / Phytochemistry 58 (2001) 463–474
Compounds 16 and 17. Treatment of 2 with 4-meth-
Compound 19. Treatment of 2 with 3-nitrobenzoyl
chloride gave 220 mg of 19. Amorphous solid. IR ꢁmax
(film) cmꢀ1: 3085, 3064, 2937, 2864, 1747, 1732, 1658,
1616, 1537, 1479, 1440, 1260, 1234, 1136, 1041, 837,
775, 719. EI–MS m/z (rel. int.): [M]+ absent, 493 [M–
NO2C6H4COOH]+ (3), 433 [M–NO2C6H4COOH–
AcOH]+ (3), 326 [M–2(NO2C6H4COOH)]+ (53), 266
[M–2(NO2C6H4COOH)–AcOH]+ (100), 251 (45), 150
oxybenzoyl chloride gave a mixture of two compounds
which were separated by CC (silica gel, petrol ether–
AcOEt 4:1, petrol ether–AcOEt 3:2 as eluent) giving 60
mg of 16 and 175 mg of 17.
Compound 16: white crystals, mp 187–190 ꢂC. IR
ꢁmax (film) cmꢀ1: 3508, 2931, 2856, 1740, 1700, 1654,
1606, 1579, 1512, 1317, 1270, 1256, 1167, 1101, 1029,
869, 771, 736. EI–MS m/z (rel. int.): 496 [M]+ (2), 478
[M–H2O]+ (6), 418 [M–H2O–AcOH]+ (16), 344 [M–
CH3OC6H5COOH]+ (3), 326 [M–CH3OC6H5COOH–
H2O]+ (32), 284 [M–CH3OC6H5COOH–AcOH]+ (18),
266 [M–CH3OC6H5COOH–AcOH–H2O]+ (80), 253
(60), 135 (100). 1H NMR (CDCl3): ꢀ 5.06 (dd, 1H, J=11.2
and 5.2 Hz, H-3b), 3.58 (t, 1H, J=3.8 Hz, H-7a), 2.67 (m,
1H, H-13), 2.26 (br s, 2H, H-15), 4.81 (br s, 1H, HA-17),
4.78 (br s, 1H, HB-17), 4.16 (d, 1H, J=11.7 Hz, HA-18),
3.56 (d, 1H, J=11.7 Hz, HB-18), 0.97 (s, 3H, Me-19), 1.14
(s, 3H, Me-20), 2.03 (s, 3H, OAc), 7.95 (d, 2H, J=6.8 Hz,
H-20 and H-60), 6.90 (d, 2H, J=6.8 Hz, H-30 and H-50),
3.83 (s, 3H, OME0). 13C NMR: Table 1b.
1
(67), 119 (24), 83 (86). H NMR (CDCl3): ꢀ 5.00 (dd,
1H, J=11.2 and 5.2 Hz, H-3b), 5.03 (t, 1H, J=3.8 Hz,
H-7a), 2.72 (m, 1H, H-13), 2.33 (dt, 1H, J=17 and 2.2
Hz, HA-15), 2.17 (dt, 1H, J=17 and 2.2 Hz, HB-15),
4.80 (br s, 1H, HA-17), 4.73 (br s, 1H, HB-17), 3.86 (d,
1H, J=11.7 Hz, HA-18), 3.54 (d, 1H, J=11.7 Hz, HB-
18), 1.00 (s, 3H, Me-19), 1.20 (s, 3H, Me-20), 1.17 (s,
3H, OAc), 8.81 (br s, 1H, H-20), 8.41 (br d, 1H, J=7.5,
H-40), 7.70 (t, 1H, J=7.5, H-50), 8.37 (br d, 1H, J=7.5,
H-60), 8.70 (br s, 1H, H-200), 8.34 (br d, 1H, J=7.5, H-
400), 7.60 (t, 1H, J=7.5, H-500), 8.24 (br d, 1H, J=7.5, H-
600). 13C NMR: Table 1c.
Compound 20. Treatment of 2 with 4-cyanobenzoyl
chloride gave 232 mg of 20. Amorphous solid. IR ꢁmax
(film) cmꢀ1: 3064, 2937, 2862, 2231, 1744, 1716, 1658,
1610, 1569, 1309, 1276, 1234, 1176, 1041, 1015, 862, 767,
736. EI–MS m/z (rel. int.): [M]+ absent, 326 [M–
2(NCC6H4COOH)]+ (24), 266 [M–2(NCC6H4COOH)–
ꢂ
Compound 17: white crystals, mp 83–86 C. IR ꢁmax
(film) cmꢀ1: 3064, 2935, 2860, 1743, 1708, 1658, 1606,
1581, 1512, 1461, 1317, 1270, 1257, 1166, 1101, 1029,
877, 771, 736. EI–MS m/z (rel. int.): [M]+ absent, 478
[M–CH3OC6H5COOH]+ (3), 326 [M–2(CH3OC6H5-
COOH)]+ (76), 266 [M–2(CH3OC5H6COOH)–AcOH]+
(100), 251 (28), 135 (96). 1H NMR (CDCl3): δ
4.97 (dd, 1H, J=11.2 and 5.2 Hz, H-3b), 4.97 (t, 1H,
J=3.8 Hz, H-7a), 2.73 (m, 1H, H-13), 2.32 (dt, 1H,
J=17 and 2.2 Hz, HA-15), 2.18 (dt, 1H, J=17 and 2.2
Hz, HB-15), 4.82 (br s, 1H, HA-17), 4.74 (br s, 1H, HB-
17), 3.76 (d, 1H, J=11.7 Hz, HA-18), 3.60 (d, 1H,
J=11.7 Hz, HB-18), 0.97 (s, 3H, Me-19), 1.20 (s, 3H,
Me-20), 1.20 (s, 3H, OAc), 8.00 (d, 2H, J=6.8 Hz, H-20
and H-60), 6.94 (d, 2H, J=6.8 Hz, H-30 and H-50), 7.91
(d, 2H, J=6.8 Hz, H-200 and H-600), 6.87 (d, 2H, J=6.8
Hz, H-300 and H-500), 3.84 (s, 3H, OME0), 3.82 (s, 3H,
OME00). 13C NMR: Table 1b.
1
AcOH]+ (44), 251 (20), 185 (16), 130 (100). H NMR
(CDCl3): ꢀ 4.96 (dd, 1H, J=11.2 and 5.2 Hz, H-3b), 4.98
(t, 1H, J=3.8 Hz, H-7a), 2.70 (m, 1H, H-13), 2.28 (dt, 1H,
J=17 and 2.2 Hz, HA-15), 2.13 (dt, 1H, J=17 and 2.2 Hz,
HB-15), 4.78 (br s, 1H, HA-17), 4.71 (br s, 1H, HB-17),
3.79 (d, 1H, J=11.7 Hz, HA-18), 3.52 (d, 1H, J=11.7
Hz, HB-18), 0.94 (s, 3H, Me-19), 1.15 (s, 3H, Me-20),
1.14 (s, 3H, OAc), 8.12 (br d, 2H, J=6.8 Hz, H-20 and
H-60), 7.75 (br d, 2H, J=6.8 Hz, H-30 and H-50), 8.00 (br
d, 2H, J=6.8 Hz, H-200 and H-600), 7.66 (br d, 2H, J=6.8
Hz, H-300 and H-500). 13C NMR: Table 1c.
Compound 21. Treatment of 2 with 4-nitrobenzoyl
chloride gave 260 mg of 21. Amorphous solid. IR ꢁmax
(film) cmꢀ1: 3057, 2935, 2862, 1743, 1722, 1656, 1606,
1529, 1344, 1276, 1234, 1118, 1103, 1041, 1014, 873,
842, 785, 736, 719. EI–MS m/z (rel. int.): [M]+ absent,
493 [M–NO2C6H4COOH]+ (1), 433 [M–NO2C6H4-
COOH–AcOH]+ (2), 326 [M–2(NO2C6H4COOH)]+
(40), 266 [M–2(NO2C6H4COOH)–AcOH]+ (100), 251
Compound 18. Treatment of 2 with 2-furoyl chloride
gave 187 mg of 18. Amorphous solid. IR ꢁmax (film) cmꢀ1
:
3124, 3064, 2937, 2862, 1744, 1714, 1660, 1579, 1569,
1471, 1394, 1299, 1232, 1180, 1120, 1041, 1012, 975, 885,
763, 736, 702. EI–MS m/z (rel. int.): [M]+ absent, 438 [M–
C4H3OCOOH]+ (2), 326 [M–2(C4H3OCOOH)]+ (50),
266 [M–2(C4H3OCOOH)–AcOH]+ (52), 251 (16), 185
(14), 95 (100). 1H NMR (CDCl3): ꢀ 4.95 (dd, 1H,
J=11.2 and 5.2 Hz, H-3b), 4.91 (t, 1H, J=3.8 Hz, H-
7a), 2.67 (m, 1H, H-13), 2.25 (dt, 1H, J=17 and 2.2 Hz,
HA-15), 2.10 (dt, 1H, J=17 and 2.2 Hz, HB-15), 4.77 (br
s, 1H, HA-17), 4.70 (br s, 1H, HB-17), 3.77 (d, 1H,
J=11.7 Hz, HA-18), 3.54 (d, 1H, J=11.7 Hz, HB-18),
0.88 (s, 3H, Me-19), 1.11 (s, 3H, Me-20), 1.37 (s, 3H,
OAc), 7.13 (m, 1H, H-30), 6.47 (m, 1H, H-40), 7.54 (m,
1H, H-50), 70.004 (m, 1H, H-300), 6.42 (m, 1H, H-400), 7.49
(m, 1H, H-5 ). 13C NMR: Table 1b.
1
(57), 185 (35), 150 (82). H NMR (CDCl3): ꢀ 5.02 (dd,
1H, J=11.2 and 5.2 Hz, H-3b), 5.04 (t, 1H, J=3.8 Hz,
H-7a), 2.77 (m, 1H, H-13), 2.33 (dt, 1H, J=17 and 2.2
Hz, HA-15), 2.20 (dt, 1H, J=17 and 2.2 Hz, HB-15),
4.85 (br s, 1H, HA-17), 4.77 (br s, 1H, HB-17), 3.86 (d,
1H, J=11.7 Hz, HA-18), 3.59 (d, 1H, J=11.7 Hz, HB-
18), 1.00 (s, 3H, Me-19), 1.22 (s, 3H, Me-20), 1.21 (s,
3H, OAc), 8.23 (br d, 2H, J=6.8 Hz, H-20 and H-60),
8.33 (br d, 2H, J=6.8 Hz, H-30 and H-50), 8.11 (br d,
2H, J=6.8 Hz, H0-0200 and H-600), 8.24 (br d, 2H, J=6.8
Hz, H-300 and H-5 ). 13C NMR: Table 1c.